中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
23期
106-107,110
,共3页
慢性胃炎%雷贝拉唑%奥美拉唑%Hp根除率
慢性胃炎%雷貝拉唑%奧美拉唑%Hp根除率
만성위염%뢰패랍서%오미랍서%Hp근제솔
Chronic gastritis%Rapeprazole%Omeprazole%Hp eradication rate
目的：探讨雷贝拉唑、克拉霉素联合阿莫西林治疗慢性胃炎的临床效果。方法将92例慢性胃炎患者随机分为观察组和对照组，各46例，观察组给予雷贝拉唑、克拉霉素、阿莫西林治疗，对照组给予奥美拉唑、克拉霉素、阿莫西林治疗，观察两组的症状、体征及Hp根除率，并进行临床疗效评价。结果观察组Hp根除率为91.30%，高于对照组的78.26%，差异有统计学意义(P<0.05)；观察组总有效率为95.65%，高于对照组的80.43%，差异有统计学意义(P<0.05)；两组患者治疗期间均未出现相关不良反应。结论雷贝拉唑治疗慢性胃炎的临床效果优于奥美拉唑。
目的：探討雷貝拉唑、剋拉黴素聯閤阿莫西林治療慢性胃炎的臨床效果。方法將92例慢性胃炎患者隨機分為觀察組和對照組，各46例，觀察組給予雷貝拉唑、剋拉黴素、阿莫西林治療，對照組給予奧美拉唑、剋拉黴素、阿莫西林治療，觀察兩組的癥狀、體徵及Hp根除率，併進行臨床療效評價。結果觀察組Hp根除率為91.30%，高于對照組的78.26%，差異有統計學意義(P<0.05)；觀察組總有效率為95.65%，高于對照組的80.43%，差異有統計學意義(P<0.05)；兩組患者治療期間均未齣現相關不良反應。結論雷貝拉唑治療慢性胃炎的臨床效果優于奧美拉唑。
목적：탐토뢰패랍서、극랍매소연합아막서림치료만성위염적림상효과。방법장92례만성위염환자수궤분위관찰조화대조조，각46례，관찰조급여뢰패랍서、극랍매소、아막서림치료，대조조급여오미랍서、극랍매소、아막서림치료，관찰량조적증상、체정급Hp근제솔，병진행림상료효평개。결과관찰조Hp근제솔위91.30%，고우대조조적78.26%，차이유통계학의의(P<0.05)；관찰조총유효솔위95.65%，고우대조조적80.43%，차이유통계학의의(P<0.05)；량조환자치료기간균미출현상관불량반응。결론뢰패랍서치료만성위염적림상효과우우오미랍서。
Objective To investigate the clinical efficacy of rabeprazole,clarithromycin combined with amoxicillin in the treatment of chronic gastritis. Methods 92 cases of patients with chronic gastritis were randomly divided into observa-tion group and control group,46 cases of each group,rapeprazole,carithomycin and amoxicillin treatment were used in observation group,omeprazole,clarithromycin and amoxicillin treatment were used in control group.Symptoms,signs and the rate of Hp eradication in two groups was observed respectively,and the clinical efficacy was evaluated. Results Hp eradication rate in observation group was 91.30%,higher than that in control group (78.26%),with statistical difference (P<0.05).The total effective rate in observation group was 95.65%,higher than that in control group(80.43%),with statis-tical difference (P<0.05).There was no related adverse reaction occurred in the two groups of patients during treatment. Conclusion The clinical effect of chronic gastris treated by rapeprazole is better than that by omeperazole.
